Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Enteric Disease Testing Market, by End User
1.4.2 Europe Enteric Disease Testing Market, by Disease Type
1.4.3 Europe Enteric Disease Testing Market, by Product Type
1.4.4 Europe Enteric Disease Testing Market, by Technique
1.4.5 Europe Enteric Disease Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
Chapter 4. Europe Enteric Disease Testing Market by End User
4.1 Europe Hospital Laboratories Market by Country
4.2 Europe Pharmaceutical & Biotechnology Companies Market by Country
4.3 Europe Academic & Research Institutes Market by Country
Chapter 5. Europe Enteric Disease Testing Market by Disease Type
5.1 Europe Bacterial Market by Country
5.2 Europe Viral Market by Country
5.3 Europe Parasitic Market by Country
Chapter 6. Europe Enteric Disease Testing Market by Product Type
6.1 Europe Reagents & Consumables Market by Country
6.2 Europe Equipment Market by Country
Chapter 7. Europe Enteric Disease Testing Market by Technique
7.1 Europe Immunodiagnostics Market by Country
7.2 Europe Molecular Diagnostics Market by Country
Chapter 8. Europe Enteric Disease Testing Market by Country
8.1 Germany Enteric Disease Testing Market
8.1.1 Germany Enteric Disease Testing Market by End User
8.1.2 Germany Enteric Disease Testing Market by Disease Type
8.1.3 Germany Enteric Disease Testing Market by Product Type
8.1.4 Germany Enteric Disease Testing Market by Technique
8.2 UK Enteric Disease Testing Market
8.2.1 UK Enteric Disease Testing Market by End User
8.2.2 UK Enteric Disease Testing Market by Disease Type
8.2.3 UK Enteric Disease Testing Market by Product Type
8.2.4 UK Enteric Disease Testing Market by Technique
8.3 France Enteric Disease Testing Market
8.3.1 France Enteric Disease Testing Market by End User
8.3.2 France Enteric Disease Testing Market by Disease Type
8.3.3 France Enteric Disease Testing Market by Product Type
8.3.4 France Enteric Disease Testing Market by Technique
8.4 Russia Enteric Disease Testing Market
8.4.1 Russia Enteric Disease Testing Market by End User
8.4.2 Russia Enteric Disease Testing Market by Disease Type
8.4.3 Russia Enteric Disease Testing Market by Product Type
8.4.4 Russia Enteric Disease Testing Market by Technique
8.5 Spain Enteric Disease Testing Market
8.5.1 Spain Enteric Disease Testing Market by End User
8.5.2 Spain Enteric Disease Testing Market by Disease Type
8.5.3 Spain Enteric Disease Testing Market by Product Type
8.5.4 Spain Enteric Disease Testing Market by Technique
8.6 Italy Enteric Disease Testing Market
8.6.1 Italy Enteric Disease Testing Market by End User
8.6.2 Italy Enteric Disease Testing Market by Disease Type
8.6.3 Italy Enteric Disease Testing Market by Product Type
8.6.4 Italy Enteric Disease Testing Market by Technique
8.7 Rest of Europe Enteric Disease Testing Market
8.7.1 Rest of Europe Enteric Disease Testing Market by End User
8.7.2 Rest of Europe Enteric Disease Testing Market by Disease Type
8.7.3 Rest of Europe Enteric Disease Testing Market by Product Type
8.7.4 Rest of Europe Enteric Disease Testing Market by Technique
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Becton, Dickinson and Company
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 SWOT Analysis
9.3 Neogen Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Acquisition and Mergers:
9.4 Bureau Veritas S.A.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Acquisition and Mergers:
9.5 SGS S.A.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental Analysis
9.5.4 Recent strategies and developments:
9.5.4.1 Partnerships, Collaborations, and Agreements:
9.6 Eurofins Scientific SE
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Recent strategies and developments:
9.6.4.1 Acquisition and Mergers:
9.7 Merck KGaA
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.8 PerkinElmer, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.9 Intertek Group PLC
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.10. TÜV Nord Group
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
Unique Offerings 